These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 19440095)

  • 1. Comments on "Optimizing early prediction for antipsychotic response in schizophrenia" by Chang et al.
    Chen L; Kollack-Walker S; Lipkovich IA
    J Clin Psychopharmacol; 2009 Jun; 29(3):311-2. PubMed ID: 19440095
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to comments on "Optimizing early prediction for antipsychotic response in schizophrenia".
    Chang YC; Lane HY
    J Clin Psychopharmacol; 2009 Aug; 29(4):391. PubMed ID: 19593183
    [No Abstract]   [Full Text] [Related]  

  • 3. On the use of discrete choice models for causal inference.
    Tchernis R; Horvitz-Lennon M; Normand SL
    Stat Med; 2005 Jul; 24(14):2197-2212. PubMed ID: 15887310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to Shen J, Kobak K, Zhao Y, et al. Use of remote centralized raters via live 2-way video ina multicenter clinical trial for schizophrenia. (J Clin Psychopharmacol. 2008;28:691-693).
    Grunze HC; Höschl C; Montgomery SA; Sartorius N; Vieta E
    J Clin Psychopharmacol; 2009 Aug; 29(4):409; author reply 409-10. PubMed ID: 19593194
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prediction of the effectiveness of neuroleptic therapy in acute schizophrenia].
    Bartkó G
    Orv Hetil; 1984 Oct; 125(43):2621-4. PubMed ID: 6149512
    [No Abstract]   [Full Text] [Related]  

  • 6. Optimizing adherence to treatment in patients with schizophrenia.
    Lacro J
    Behav Healthc; 2006 Aug; 26(8):38-42. PubMed ID: 16961044
    [No Abstract]   [Full Text] [Related]  

  • 7. Comments from a keen reader.
    Morgan L
    Aust Fam Physician; 1993 Oct; 22(10):1885-6. PubMed ID: 7904152
    [No Abstract]   [Full Text] [Related]  

  • 8. Ghrelin and leptin levels in schizophrenic patients treated with antipsychotic monotherapy.
    Sentissi O; Grouselle D; Viala A; Bourdel MC; Olié JP; Epelbaum J; Poirier MF
    J Clin Psychopharmacol; 2009 Jun; 29(3):304-6. PubMed ID: 19440091
    [No Abstract]   [Full Text] [Related]  

  • 9. Schizophrenia. New drugs, renewed hope.
    Mayo Clin Health Lett; 2002 Oct; 20(10):7. PubMed ID: 12425272
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuroprotection: a new strategy in the treatment of schizophrenia. Early detection and intervention.
    Perkins DO
    CNS Spectr; 2007 Oct; 12(10 Suppl 18):10-3. PubMed ID: 19322959
    [No Abstract]   [Full Text] [Related]  

  • 11. The co-occurrence of schizophrenia and alcoholism: comments on Michael Soyka's editorial.
    Heinz A; Mann K
    Addiction; 2000 Dec; 95(12):1863-4. PubMed ID: 11218364
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clozapine in the treatment of under-age schizophrenia].
    Haapasalo-Pesu KM
    Duodecim; 2009; 125(15):1635-8. PubMed ID: 19769179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. At risk mental states.
    Filaković P; Degmecić D; Koić E; Benić D
    Psychiatr Danub; 2008 Mar; 20(1):97. PubMed ID: 18376340
    [No Abstract]   [Full Text] [Related]  

  • 14. Further clinical experience with oxyprothepin-decanoate.
    Kalvach Z; Hálková E; Bastecký J
    Act Nerv Super (Praha); 1981 Dec; 23(4):271-2. PubMed ID: 6121440
    [No Abstract]   [Full Text] [Related]  

  • 15. Capitalizing on extrasynaptic glutamate neurotransmission to treat antipsychotic-resistant symptoms in schizophrenia.
    Krystal JH
    Biol Psychiatry; 2008 Sep; 64(5):358-60. PubMed ID: 18694665
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antipsychotic agents are best chosen by their adverse effect profile].
    Msghina M; Lindefors N
    Lakartidningen; 2009 Oct 28-Nov 3; 106(44):2841-2, 2844-6. PubMed ID: 19967963
    [No Abstract]   [Full Text] [Related]  

  • 17. Note on the scientific paper "Intraocular pressure in schizophrenic patients treated with psychiatric medications.".
    Moura Filho FJ; Souza VB
    Arq Bras Oftalmol; 2008; 71(6):909-10. PubMed ID: 19169503
    [No Abstract]   [Full Text] [Related]  

  • 18. Microglial activation in schizophrenia and minocycline treatment.
    Hashimoto K
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1758-9; author reply 1760. PubMed ID: 18652869
    [No Abstract]   [Full Text] [Related]  

  • 19. The ethics of identifying and treating psychosis early.
    Agius M; Bradley V; Ryan D; Zaman R
    Psychiatr Danub; 2008 Mar; 20(1):93-6. PubMed ID: 18376339
    [No Abstract]   [Full Text] [Related]  

  • 20. Response to Kujawa et al. letter-to-the-editor.
    Sethuraman G; Taylor CC; Enerson M; Dunayevich E
    Schizophr Res; 2006 May; 84(1):172-3. PubMed ID: 16563702
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.